This inventor holds 7 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: United Therapeutics Corporation, Cbmed Gmbh Center for Biomarker Research in Medicine, Joanneum Research Forschungsgesellschaft Mbh. Active years: 2011-2022.
Company Filing History:
5 out of 133 
1 out of 2 
1 out of 22 
Years Active: 2011-2022
Title: Horst Olschewski: Innovator in Pulmonary Health
Introduction
Horst Olschewski, an esteemed inventor located in Graz, Austria, has made significant contributions to the field of pulmonary health. With a portfolio of 7 patents, he has focused on innovative solutions aimed at improving patient treatment and diagnostic methods.
Latest Patents
Olschewski's latest innovations include a groundbreaking method for administering Treprostinil by inhalation. This invention allows the drug to be delivered using a metered dose inhaler, offering patients greater autonomy in managing their condition. Additionally, he has developed a method for diagnosing pulmonary hypertension (PH), which includes monitoring the disease's progression, determining severity, and differentiating it from other related conditions. His innovations also encompass kits designed to facilitate these diagnostic procedures.
Career Highlights
Throughout his career, Horst Olschewski has collaborated with reputable organizations such as United Therapeutics Corporation and Siemens Aktiengesellschaft. His work has had a considerable impact on the improvement of treatments available for pulmonary diseases, underscoring his dedication to healthcare advancements.
Collaborations
Olschewski has worked alongside accomplished professionals, including Robert Roscigno and Lewis J. Rubin. This collaboration has enriched his work and contributed to the innovation of effective medical solutions.
Conclusion
Horst Olschewski's contributions to the field of pulmonary health through his inventive spirit and collaborations reflect his commitment to enhancing patient care. As he continues to innovate, the healthcare industry can expect to benefit from his unique insights and expertise.